-
Use of enhanced recovery after surgery in children with obstructive sleep apnea syndrome during the perioperative period
- LIU Dawei, ZHANG Yu, LI Chenglin, CHEN Xiumei, SONG Xicheng
-
J Otolaryngol Ophthalmol Shandong Univ. 2018, 32(5):
19-22.
doi:10.6040/j.issn.1673-3770.1.2018.011
-
Abstract
(
1597 )
PDF (401KB)
(
547
)
Save
-
References |
Related Articles |
Metrics
Objective To explore the effects of enhanced recovery after surgery(ERAS)in children with obstructive sleep apnea syndrome(OSAS)during the perioperative period. Methods A total of 1 968 children who underwent adenoidal ablation and bilateral tonsillectomy under nasal endoscopy were randomly divided into the ERAS group(1 040 patients)and the traditional group(928 patients). The ERAS group was treated with the ERAS mode during the perioperative period, whereas the traditional group was treated with the traditional perioperative management. The postoperative hospital stay, incidence of complications, pain scores, mental status, and postoperative diet between the two groups were compared. Results The postoperative hospital stays were significantly shorter in the ERAS group than in the traditional group ［(2.3±0.8)days vs(3.5±1.2)days］; t=-5.529, P=0.001). The complication rate was lower in the ERAS group than in the traditional group ［0.19% vs 1.29%; χ2=8.413, P=0.004). The pain scores were 2.42±0.89, 3.40±0.82, and 3.12±0.62 at 2, 12, and 24 h after perioperative management in the traditional group, whereas the corresponding values in the ERAS group were 1.69±0.58, 2.32±0.69, and 2.13±0.42(all P<0.01). The mental status scores at 6, 12, and 24 h were 5.42±0.89, 3.40±0.82, and 3.12±0.75, respectively, in the traditional group and 3.36±0.57, 2.55±0.50, and 1.65±0.45, respectively, in the ERAS group(all P<0.01). The cold fluid diets at 6, 12, and 24 h after surgery were 2.0±1.2, 16.5±2.6, and 24.0±13.0 mL, respectively, in the traditional group and 5.0±1.8, 26.5±5.8, and 68±26 mL, respectively, in the ERAS group(all P<0.01). Conclusion ERAS is effective for children with OSAS undergoing nasal endoscopic adenoidectomy ablation and tonsil resection during the perioperative period.
